ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 41 filers reported holding ATYR PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2019$017
-67.3%
0.00%
Q1 2019$0520.0%0.00%
Q4 2018$0520.0%0.00%
Q3 2018$052
+477.8%
0.00%
Q3 2017$09
+28.6%
0.00%
Q1 2017$0
-100.0%
7
-97.9%
0.00%
Q3 2015$3,000
-62.5%
331
-19.5%
0.00%
Q2 2015$8,0004110.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$5,082,0005.46%
RIVERHEAD CAPITAL MANAGEMENT LLC 518,910$22,422,0000.35%
TANG CAPITAL MANAGEMENT LLC 279,425$777,0000.35%
JACKSON PARK CAPITAL, LLC 66,000$183,0000.25%
Rock Springs Capital Management LP 433,500$1,205,0000.09%
TIVERTON ASSET MANAGEMENT LLC 347,748$967,0000.04%
Alyeska Investment Group, L.P. 950,461$2,642,0000.02%
TFS CAPITAL LLC 23,449$65,0000.01%
Dynamic Technology Lab Private Ltd 14,858$41,0000.01%
Magnetar Financial LLC 138,459$385,0000.01%
View complete list of ATYR PHARMA INC shareholders